Intratracheal Instillation of Budesonide–Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants

Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns – A systematic review

(2022) Lucas Hirano Arruda Moraes et al.   Jornal de Pediatria

Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus

(2022) Tim Hundscheid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intra‐tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants

(2021) Laura Moschino et al.   PEDIATRIC PULMONOLOGY

A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia

(2021) Manizheh Gharehbaghi et al.   Oman Medical Journal

Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)

(2020) Cindy T. McEvoy et al.   PEDIATRIC RESEARCH

Nebulized Inhaled Corticosteroids in Asthma Treatment in Children ≤5 Years of Age: A Systematic Review and Global Expert Analysis

(2020) Jian Guo Hong et al.   Journal of Allergy and Clinical Immunology-In Practice

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants: An Evidence-Based Approach

(2019) Erik A Jensen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Surfactant and budesonide for respiratory distress syndrome: an observational study

(2019) T. Brett Kothe et al.   PEDIATRIC RESEARCH

PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age

(2018) Ronald I. Clyman et al.   JOURNAL OF PEDIATRICS

Relationship between Measures of Neonatal Glycemia, Neonatal Illness, and 2-Year Outcomes in Very Preterm Infants

(2017) Anna Catherine Tottman et al.   JOURNAL OF PEDIATRICS

Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia

(2016) Tsu F. Yeh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Antiinflammatory Effects of Budesonide in Human Fetal Lung

(2016) Anne Marie Barrette et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The Addition of Inhaled Budesonide to Standard Therapy Shortens the Length of Stay in Hospital for Asthmatic Preschool Children: A Randomized, Double-Blind, Placebo-Controlled Trial

(2015) Cem Hasan Razi et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Comparative Effectiveness of Surfactant Preparations in Premature Infants

(2013) Andrea Trembath et al.   JOURNAL OF PEDIATRICS

General and Respiratory Health Outcomes in Adult Survivors of Bronchopulmonary Dysplasia

(2011) Aisling Gough et al.   CHEST

Prevalence and Determinants of Hyperglycemia in Very Low Birth Weight Infants: Cohort Analyses of the NIRTURE Study

(2010) Kathryn Beardsall et al.   JOURNAL OF PEDIATRICS

Target Ranges of Oxygen Saturation in Extremely Preterm Infants

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia

(2010) K. L. Watterberg et al.   PEDIATRICS

Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network

(2010) B. J. Stoll et al.   PEDIATRICS

Early Intratracheal Instillation of Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants: A Pilot Study

(2008) T. F. Yeh et al.   PEDIATRICS